Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study - Conter, V; Bartram, C R; Valsecchi, M G (Blood, 2010)
et al.